PATENT CLAIM ANALYSIS

Application Number: 16396135
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-09
Patent Classification: ["424", "427000"]

Abstract:
The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.

Claim (Index 24):
A method of treating an inflammatory disease or disorder in a subject in need thereof, the method comprising administering to the subject an article in an amount sufficient to treat the inflammatory disease or disorder in the subject, wherein the article comprises a compound of formula (A-VIII):\n D1-L-D2\u2003\u2003(A-VIII) or a pharmaceutically acceptable salt thereof, wherein (i) each of D1 and D2 is, independently, a radical formed from a steroid; and L is a linker covalently linking D1 to D2, (ii) at least 70% (w/w) of the article is the compound of formula (A-VIII), and (iii) the article is free of controlled release excipient.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 100.0
- Lexical Diversity: 1.18182
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16396400', '14436657', '15305845', '14651097', '13606949']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6772779284418818
- 35 USC 102 Novelty (BERT): 0.5344765264314035
- Combined Prediction Score: 0.662997788240834
- Mean Citation Score: 231.399632
- Max Citation Score: 347.4539200000001
- Similarity Product: 244.75594455504424

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test